Tag: Henry He
Fangda, MoFo steer USD900m Boomray-Novartis licence agreement
Boomray Pharmaceuticals enters into an exclusive global licence agreement valued at up to USD900 million with Novartis for a preclinical radioligand therapy
Firms act on USD2.5bn US-Korean AI-driven drug discovery pact
Firms assists on US-South Korea AI driven drug discovery collaboration between Insilico Medicine and SK Biopharmaceuticals
Fangda Partners beefs up biopharmacy, aircraft leasing practices
Fangda Partners has hired Shanghai-based Henry He and Guangzhou-based Judy Tan as partners to grow the firm’s biopharmaceutical and aircraft leasing business
LATEST ON LAW.ASIA
MOST READ ON LAW.ASIA
Climate-proofing India’s next model BIT
India’s 2026 model BIT must align investment protection with climate obligations for long-term treaty coherence
